Endothelium-derived nitric oxide relaxes nonvascular smooth muscle
- 1 February 1989
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 161 (1), 61-72
- https://doi.org/10.1016/0014-2999(89)90180-5
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- EDRF generation and release from perfused bovine pulmonary artery and veinEuropean Journal of Pharmacology, 1988
- Anion exchange resins discriminate between nitric oxide and EDRFEuropean Journal of Pharmacology, 1987
- Comparative pharmacology of EDRF and nitric oxide on vascular stripsEuropean Journal of Pharmacology, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factorNature, 1986
- The Role of Endothelium in the Responses of Vascular Smooth Muscle to DrugsAnnual Review of Pharmacology and Toxicology, 1984
- Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitriteCanadian Journal of Physiology and Pharmacology, 1981
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferensNature, 1977
- Effects of Potassium Chloride and Smooth Muscle Relaxants on Tension and Cyclic Nucleotide Levels in Rat MyometriumCanadian Journal of Physiology and Pharmacology, 1975